Akorn, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

AKRX 46.11 -0.22 (-0.47%)
price chart
Akorn Inc. has customer database stolen, records offered to highest bidder
Akorn Inc., a niche pharmaceutical company Lake Forest, IL, has had a customer database with more than 50,000 records compromised by a hacker who is offering to sell the data to the highest bidder or back to the company, whichever comes first.
Zacks Rating on Akorn, Inc.
Susquehanna initiates coverage on Akorn, Inc. (NASDAQ:AKRX).The analysts at the brokerage house have a current rating of Neutral on the shares.
Large Inflow of Money Witnessed in Akorn, Inc.  OTC Outlook
Akorn Receives Average Rating of "Buy" from Analysts (NASDAQ:AKRX)  sleekmoney
Shares of Akorn, Inc. (NASDAQ:AKRX) Sees Large Outflow of Money
Akorn, Inc. (NASDAQ:AKRX) traded higher in the last at $46.25, gaining 0.24 points or 0.52%. From the data available, it can be said that the stock did not make an impact in the money flow department with the net figure coming to be $(-1) million.
Stock Update: Akorn, Inc. (NASDAQ:AKRX)  Markets Daily
Will Akorn, Inc. (NASDAQ:AKRX) Surprise Analysts?  Investor Newswire
Pharma Pair Trade? Susquehanna Starts Lannet At Buy, Akorn At Neutral
In separate reports published Monday, Susquehanna Financial Group analyst Andrew Finkelstein initiated coverage of Lannet Company, Inc. (NYSE: LCI) with a Buy rating and $75 price target and Akorn, Inc. (NASDAQ: AKRX) with a Neutral rating and $48 ...
Susquehanna Rating Update on Akorn, Inc. (NASDAQ:AKRX)  Insider Trading Report
Akorn Inc (NASDAQ:AKRX) Coverage Started by Susquehanna. The Firm's ...  OctaFinance.com
Analysts Disagree Over Significance of Akorn, Inc.'s Financial Errors (AKRX)
Akorn, Inc. (NASDAQ:AKRX) announced on Friday that it will have to restate financials from 2014 due to accounting errors.
Akorn Inc. (AKRX) Is Losing Ground After Restatement Announcement  Nasdaq
Why Akorn, Inc. Sky-rocketed Higher Today
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Akorn, Inc. (NASDAQ:AKRX) close to 52-week high on important volume  Markets Wired
Akorn (AKRX) Stock Soars Today After Fourth Quarter Earnings, Revenue Beat  TheStreet.com
Stock Technical Report on Akorn Inc (NASDAQ:AKRX)
Akorn Inc (NASDAQ:AKRX) (TREND ANALYSIS) shares were traded with thin volume. The stock closed last trading session at a price of $45.86, down by -1.82%, with a volume of 1,354,834 shares against an average volume for the last 3 months of 2,358,250 ...
Raymond James Initiates Coverage on Akorn (AKRX)  The Legacy
4 Specialty Pharmaceutical Stocks Could Be the Next Takeover Candidates
Akorn Inc. (NASDAQ: AKRX) is engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.
Akorn, Inc. (NASDAQ:AKRX) Short Interest Update
Akorn, Inc. (NASDAQ:AKRX) stated loss of 1,455,608 shares or 16.7% in the short interest. The short interest registered from 8,709,502 on June 30,2015 to 7,253,894 on July 15,2015.
Company Shares of Akorn, Inc. Drops by -0.33%  OTC Outlook
Analysts Set Akorn Price Target at $54.46 (NASDAQ:AKRX)  WKRB News
Akorn, Inc. (NASDAQ:AKRX) Price Target Update
Akorn, Inc. (NASDAQ:AKRX): 11 analysts have set the short term price target of Akorn, Inc. (NASDAQ:AKRX) at $55.36.
Stocks in Review- Akorn (AKRX), Neurocrine (NBIX), Royal Caribbean (RCL ...  Investor Wired
Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest EPS ...  Benzinga